As EPSO, the EU’s flagship entry exam, returns after seven years, a parallel industry steps in: private coaching companies offering candidates an edge in one of Europe’s toughest competitions. #EuXl ...

Max Verstappen set the fastest time 30 minutes into the afternoon session, but was pushed down to second by Piastri an hour ...

Alas, there are no homunculi crammed inside the smallest human cells. Yet recent research in fertility and urology suggests Hartsoeker’s image could work metaphorically: Sperm can be a proxy for the ...

The Trump administration is demanding additional student enrollment data from federally funded universities to ensure they're no longer using affirmative action methods in their admissions processes.

Events promoting workplace relationships are an ideal way to encourage communication and trust between staff members. But it’s best to match the challenge to employees’ abilities ...

No-code and low-code platforms are reducing reliance on heavy IT resources, allowing finance teams to lead AI adoption and apply their domain expertise directly. Clear business logic, data readiness ...

The Engineering Programmes at DPGU's School of Technology & Research aim to provide a balanced blend of academic rigour, practical exposure and industry alignment. By offering flexible entry points ...

The question is no longer whether China will take part in global ocean governance, but whether it aims to shape it-- and potentially lead it.

The Quiet NZ$3.39 Billion Story You don’t often see a small advanced economy rewrite part of its migration architecture—and almost immediately get a 48‑fold uplift in committed investment. Yet that’s ...

Artificial intelligence (AI) is everywhere now. Even everyday tools like Word and Excel come with built-in AI. There is a lot of noise in the media Artificial intelligence (AI) is everywhere now. Even ...

In its first trading update since bringing IPG into the fold, Omnicom reported fourth-quarter revenue of $5.53bn, topping analysts’ expectations of $5.04bn. Total full-year revenue was $17.3bn, versus ...

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, today announced that it will ...